Trial of Tian Jiu Therapy for Allergic Rhinitis (NCT02470845) | Clinical Trial Compass
CompletedNot Applicable
Trial of Tian Jiu Therapy for Allergic Rhinitis
China136 participantsStarted 2014-07
Plain-language summary
The aim of this study is to investigate the efficacy and safety of Tian Jiu in the treatment of allergic rhinitis compared with placebo and waitlist patients in Hong Kong.
Who can participate
Age range3 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Positive skin prick tests
* High circulating levels of allergen-specific IgE antibody detected by a specific blood test for allergy called radioallergosorbent test (RAST)\]
* Clinical history or allergen to have been identified
* Nasal provocation (test)
Exclusion Criteria:
* Allergic asthma, moderate to severe atopic dermatitis, autoimmune disorders, severe chronic inflammatory diseases, history of anaphylactic reactions, hypersensitivity to cetirizine or related drugs, specific immunotherapy during the past 3 years or planned in the next 2 years, pregnancy or breastfeeding.